Stocks HNVR Financial statements
Financial statementsHanover Bancorp, Inc. /MD financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Hanover Bancorp, Inc. /MD files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Selling and marketing | 0.3 | 0.12 | 0.35 | |||
| Interest expense | 13 | 6.97 | 7.18 | 50.6 | ||
| Pre-tax income | 6.21 | 14.1 | 30.5 | 20.2 | 16.4 | 9.95 |
| Income tax | 1.24 | 3.2 | 6.94 | 5.02 | 4.03 | 2.47 |
| Net income | 4.97 | 10.9 | 23.6 | 15.2 | 12.3 | 7.49 |
| EPS, basic | 1.20 | 2.32 | 3.74 | 2.07 | 1.67 | 1.01 |
| EPS, diluted | 1.18 | 2.28 | 3.68 | 2.05 | 1.66 | 1.00 |
| Shares, basic (weighted) | 4.16 | 4.58 | 6.07 | 7.04 | 7.16 | 7.26 |
| Shares, diluted (weighted) | 4.23 | 4.66 | 6.16 | 7.12 | 7.19 | 7.26 |
| Dividend per share | 0.10 | 0.10 | 0.10 | 0.10 |
Balance sheet
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 80.2 | 167 | 150 | 193 | 163 | 209 |
| Property, plant and equipment | 14.2 | 15 | 14.5 | 16.1 | 15.3 | 14.3 |
| Lease right-of-use assets | 10.2 | 8.34 | 9.86 | |||
| Goodwill | 1.9 | 19.2 | 19.2 | 19.2 | 19.2 | 19.2 |
| Intangible assets | 0.48 | 0.4 | 0.33 | 0.25 | 0.2 | |
| Total assets | 852 | 1,485 | 1,840 | 2,150 | 2,312 | 2,383 |
| Short-term debt | 85.2 | 160 | 102 | 180 | 108 | 101 |
| Total liabilities | 774 | 1,362 | 1,667 | 1,964 | 2,115 | 2,183 |
| Paid-in capital | 63.7 | 97.2 | 127 | 126 | 125 | 123 |
| Retained earnings | 14.1 | 25 | 46.5 | 58.7 | 67.9 | 72.4 |
| Other comprehensive income | 0.16 | 0.26 | -0.62 | -1.32 | -1.33 | -0.68 |
| Shareholders' equity | 78 | 123 | 173 | 186 | 197 | 200 |
| Total equity | 78 | 123 | 173 | 186 | 197 | 200 |
| Total liabilities and equity | 852 | 1,485 | 1,840 | 2,150 | 2,312 | 2,383 |
| Shares outstanding | 4.18 | 5.56 | 7.29 | 7.17 | 7.15 | 7.14 |
Cash flow statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | 4.97 | 10.9 | 23.6 | 15.2 | 12.3 | 7.49 |
| Depreciation and amortization | 1.34 | 1.44 | 1.66 | 1.81 | 2.09 | 2.01 |
| Stock-based compensation | 0.77 | 0.9 | 1.68 | 1.87 | 1.59 | 1.57 |
| Deferred income tax | -1.11 | 0.01 | 1.79 | 1.4 | 0.59 | 1.71 |
| Cash from operations | 0.57 | 13.2 | 25.1 | 16.4 | 5.44 | 13.1 |
| Capital expenditures | -1.09 | -2.08 | -1.12 | -3.41 | -1.29 | -0.87 |
| Acquisitions | 0 | -33 | 0 | |||
| Purchases of investments | -5 | -4.7 | -8 | 0 | -623 | -131 |
| Sales and maturities of investments | 0.03 | 0.34 | 0.34 | 0.05 | 599 | 109 |
| Cash from investing | -7.29 | 89.9 | -374 | -256 | -45.4 | -27.9 |
| Stock issued | 0.11 | 0.11 | 27.7 | 0 | 0.1 | |
| Share buybacks | 0 | -1.83 | ||||
| Dividends paid | 0 | -2.04 | -2.93 | -2.96 | -3.01 | |
| Cash from financing | -0.9 | -16.7 | 332 | 283 | 25.6 | 60.9 |
| Net change in cash | -7.62 | 86.3 | -16.6 | 42.7 | -14.4 | 46 |
| Free cash flow | -0.53 | 11.1 | 24 | 13 | 4.15 | 12.2 |
| Interest paid | 13.2 | 7.1 | 7.55 | 49.6 | 80.1 | 69.8 |
| Income taxes paid | 1.24 | 1.38 | 6.47 | 4.4 | 4.03 | 2.58 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Effective tax rate | 28.3% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 4.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.4% | Net income / average total assets. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Net income growth, 1y | -39.3% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -31.8% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 8.5% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | -39.8% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -35.2% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | -3.3% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 139.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -19.6% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 87.3% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 193.7% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -20.2% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 0.0% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | 0.0% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 1.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 5.1% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 20.7% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 3.1% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 9.0% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 22.9% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 1.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 5.7% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 11.4% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Liabilities / assets | 91.3% | Total liabilities / total assets. |
| Goodwill and intangibles / assets | 0.8% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $183.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| FCF conversion | 272.2% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 4.4% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.31 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| FCF per share | $3.57 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $3.73 | Cash from operations / diluted weighted shares. |
| Book value per share | $28.74 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $26.02 | Tangible book value / shares outstanding. |
| Cash per share | $20.02 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 31.7% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 11.6% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $187.0M | Share price x shares outstanding. |
| Enterprise value | $45.8M | Market cap + total debt - cash - short-term investments. |
| P/E | 19.8x | Market cap / net income. Only when net income is positive. |
| P/B | 0.92x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.02x | Market cap / tangible book value, when positive. |
| P/FCF | 7.26x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 6.95x | Market cap / cash from operations, when positive. |
| EV/FCF | 1.78x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 13.8% | Free cash flow / market cap. |
| Earnings yield | 5.1% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 1.6% | Dividends paid over the period / market cap. |
| Shareholder yield | 1.6% | (Dividends paid + share buybacks) / market cap. |
Was Hanover Bancorp, Inc. /MD profitable in fiscal 2025?
Yes. Net income was $7.5M, a net margin of -.
How much free cash flow did Hanover Bancorp, Inc. /MD generate in fiscal 2025?
Cash from operations of $13.1M minus capital expenditures of $869.0K left free cash flow of $12.2M.